Caring for the Uninsured with Prostate Cancer: A Comparison of Four Policy Alternatives in California
- PMID: 19911260
- DOI: 10.1007/s10900-009-9199-8
Caring for the Uninsured with Prostate Cancer: A Comparison of Four Policy Alternatives in California
Abstract
The IMPACT Program seeks to improve access to prostate cancer care for low-income, uninsured men. The objective of the current study was to compare the cost-effectiveness of four policy alternatives in treating this population. We analyzed the cost-effectiveness of four policy alternatives for providing care to low-income, uninsured men with prostate cancer: (1) IMPACT as originally envisioned, (2) a version of IMPACT with reduced physician fees, (3) a hypothetical Medicaid prostate cancer treatment program, and (4) the existing county safety net. We calculated cost-effectiveness based on incremental cost-effectiveness ratios (ICERs) with the formula ICER = (Cost(alternative strategy) - Cost(baseline strategy)) / (QALY(alternative strategy) - QALY(baseline strategy)). We measured outcomes as quality-adjusted life years (QALYs). "Best-case" scenarios assumed timely access to care in 50% of cases in the county system and 70% of cases in any system that reimbursed providers at Medicaid fee-for-service rates. "Worst-case" scenarios assumed timely access in 35 and 50% of corresponding cases. In fiscal year 2004-2005, IMPACT allocated 11% of total expenditures to administrative functions and 23% to fixed clinical costs, with an overall budget of $5.9 million. The ICERs ($/QALY) assuming "best-case" scenarios for original IMPACT, modified IMPACT, and a hypothetical Medicaid program were $32,091; $64,663; and $10,376; respectively. ICERs assuming "worst-case" scenarios were $27,189; $84,236; and $10,714; respectively. County safety net was used as a baseline. In conclusion, IMPACT provides underserved Californians with prostate cancer care and value-added services with only 11% of funds allocated to administrative fixed costs. Both the original IMPACT program and the hypothetical Medicaid prostate cancer program were cost-effective compared to the county safety net, while the reduced-fees version of IMPACT was not.
Similar articles
-
Prostate cancer survivorship: lessons from caring for the uninsured.Urol Oncol. 2012 Jan-Feb;30(1):102-8. doi: 10.1016/j.urolonc.2011.09.001. Epub 2011 Nov 27. Urol Oncol. 2012. PMID: 22127017 Free PMC article. Review.
-
Cost-effectiveness of financial incentives for improving diet and health through Medicare and Medicaid: A microsimulation study.PLoS Med. 2019 Mar 19;16(3):e1002761. doi: 10.1371/journal.pmed.1002761. eCollection 2019 Mar. PLoS Med. 2019. PMID: 30889188 Free PMC article.
-
Outcomes in men denied access to a California public assistance program for prostate cancer.Public Health Rep. 2007 Mar-Apr;122(2):217-23. doi: 10.1177/003335490712200211. Public Health Rep. 2007. PMID: 17357364 Free PMC article.
-
Access to Federally Qualified Health Centers and Emergency Department Use Among Uninsured and Medicaid-insured Adults: California, 2005 to 2013.Acad Emerg Med. 2019 Feb;26(2):129-139. doi: 10.1111/acem.13494. Epub 2019 Jan 16. Acad Emerg Med. 2019. PMID: 30648780 Free PMC article.
-
The long-term cost effectiveness of treatments for benign prostatic hyperplasia.Pharmacoeconomics. 2006;24(2):171-91. doi: 10.2165/00019053-200624020-00006. Pharmacoeconomics. 2006. PMID: 16460137 Review.
Cited by
-
Prostate cancer survivorship: lessons from caring for the uninsured.Urol Oncol. 2012 Jan-Feb;30(1):102-8. doi: 10.1016/j.urolonc.2011.09.001. Epub 2011 Nov 27. Urol Oncol. 2012. PMID: 22127017 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical